Kolbeck Roland Wilhelm 4
4 · Aclaris Therapeutics, Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Aclaris (ACRS) CSO Roland Kolbeck Receives RSU Award
What Happened
Roland Wilhelm Kolbeck, Chief Scientific Officer of Aclaris Therapeutics (ACRS), received two grants of derivative awards on February 2, 2026: 95,700 and 334,900 restricted stock units (RSUs), totaling 430,600 RSUs. The Form 4 reports these as acquired at $0.00 per unit (derivative awards), i.e., no cash paid at grant.
Key Details
- Transaction date: 2026-02-02 (Form filed 2026-02-06).
- Grants: 95,700 RSUs and 334,900 RSUs; total = 430,600 RSUs.
- Reported price/value on Form 4: $0.00 (derivative award reporting).
- Shares owned after transaction: not specified in the provided excerpt.
- Footnotes:
- F1: Each RSU represents a contingent right to receive one share of common stock.
- F2: These RSUs vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026 (i.e., over four years), subject to Kolbeck’s continuous service.
- F3: Notes a standard four-year option vesting pattern (25% per year) if an option component applies.
- Timeliness: The Form 4 was filed four days after the transaction (Feb 6 vs. Feb 2); this is beyond the typical two-business-day reporting window for Section 16 insiders and therefore appears late.
Context
These entries are awards/compensation (RSUs), not open-market purchases or sales. RSU grants are common executive compensation and vest over time, so they reflect future potential share delivery contingent on continued service rather than an immediate purchase or sale. The filing’s delayed date is factual and may be noted by investors tracking insider reporting timeliness.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-02-02+95,700→ 95,700 total→ Common Stock (95,700 underlying) - Award
Employee Stock Option (Right to Buy)
[F3]2026-02-02+334,900→ 334,900 totalExercise: $3.61Exp: 2036-02-01→ Common Stock (334,900 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F3]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.